ABT vs TMP
Abbott Laboratories (ABT) versus Tompkins Financial Corporation (TMP) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Tompkins Financial Corporation (TMP) is a banks - regional company listed on AMEX.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported TMP revenue for 2024-12-31 was $79.3M. Net income was $71.0M. Revenue was up 5.7% from 2023-12-31 to 2024-12-31. TMP currently screens at market cap $1.26B and trailing P/E 7.5.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. TMP currently screens at market cap $1.26B and trailing P/E 7.5.
Not investment advice. Open the ABT and TMP stock pages for the full models.
Not investment advice.